“Quietly” Testing Famotidine for COVID-19

Yesterday, I received two emails (first from Steven Liu) about an article in Science and today I’ve already seen this article is referenced in a CNN report:

New York Clinical Trial Quietly Tests Heartburn Remedy Against Coronavirus

Key points:

  • In China, a review of ~6000 patients suggested lower mortality in those taking famotidine (not statistically significant)
  • Famotidine may interfere with viral replication protease in the coronavirus based on computer modeling
  • A randomized trial with IV famotidine (large quantities are not available) is underway in New York using 9 times the dose used for heartburn.
  • The article notes that increased heart problems are common in those with reduced renal function
  • “We still don’t know if it will work or not”

My take: Famotidine may be a hot commodity –at least until studies are completed.  Based on experience with hydroxychloroquine, some of our patients may need to look for alternative acid blockers.

Related blog posts:



3 thoughts on ““Quietly” Testing Famotidine for COVID-19

  1. Pingback: Costly Free COVID-19 Testing and Timely Tweets | gutsandgrowth

  2. Pingback: COVID-19 in Children from Italy | gutsandgrowth

  3. Pingback: Use of Famotidine for COVID-19 | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.